Introduction
Tuberculosis remains the most common cause of death from an identifiable infectious agent worldwide; this partly is a reflection of the inadequate protection afforded by the only available vaccine, BCG (1-3). A problem also exists in the diagnosis of infection with Myobacterium tuberculosis by skin testing, as the only available tuberculin purified protein derivative is insufficiently sensitive and specific (4, 5) . These difficulties may reflect downmodulation of the host immune response by mycobacterial constituents; for example, both arabinogalactan and purified protein derivative can induce suppression by monocytes of cellular immune responses in vitro (6, 7) . Such suppression may explain both the cutaneous skin test anergy exhibited by some patients with active tuberculosis, and the relative lack of efficacy of a whole mycobacterial vaccine. Purified mycobacterial antigens, therefore, could be ofparticular value for use as skin test reagents and vaccines.
Specific antimycobacterial MAbs are essential tools in the identification of species-restricted antigens. A workshop sponsored by the World Health Organization summarized the characteristics of 31 such antibodies, all of murine origin (8) . The proteins they recognized ranged in mol wt from 12 ,000 to 80,000. The genes for several of these proteins have been cloned in Escherichia coli, and study oftheir potential value as vaccines is underway.
The use of immunized animals in the identification of potential protective vaccines is, however, not without disadvantages. Heating of mycobacteria before immunization causes considerable loss of antigenic reactivity by denaturation (9) , and secreted antigens are inadequately represented in preparations of whole or disrupted organisms. Although immunization with heat-killed mycobacteria generated T lymphocytes capable of transferring delayed type hypersensitivity, inoculation with viable organisms is required to transfer protective immunity (10) . Furthermore Sonication was performed using a 150-W ultrasound probe for 30 min with the sample chilled on ice. Culture filtrates were dialyzed against water using a Spectrapor 2 membrane (Spectrum Medical, Los Angeles, CA), filtered through a 0.45-,um filter, and lyophilized. Protein concentrations of the antigens were determined spectrophotometrically using protein assay (Bio-Rad Laboratories, Richmond, CA avium-intracellulare (10 ,g/ml), or immunoaffinity-purified M. tuberculosis arabinogalactan, arabinomannan, or antigen 5 (2 yg/ml). After overnight incubation, nonspecific adsorption of protein was blocked with 0.5% BSA (Sigma Chemical Co., St. Louis, MO) in PBS for I h at 370C. Plates were washed and 0.05 ml of experimental or control supernatant was added. After 6 h plates were washed and 0.05 ml of goat anti-human polyvalent Ig alkaline phosphatase conjugate (Sigma Chemical Co.) diluted 1:500 in 1% BSA/PBS was added. After 3 h plates were washed and 0.05 ml of disodium p-nitrophenyl phosphate
(1 mg/ml) in 0.05 M sodium carbonate buffer, pH 9.8, with 0.02% MgCI2 was added. OD at 405 nm was determined with an automated reader. In some experiments monospecific anti-human IgG, IgA, and IgM (diluted 1:1,000) were used in place of the polyvalent conjugate.
Radial immunodiffusion. Ig concentration of cell supernatants was estimated using standard techniques (1 1). 50 ,l of 50-fold concentrated samples was added to wells in agarose containing monospecific antiserum for low levels of IgG or IgM (Kallestad Laboratories, Inc., Kalamazoo, MI). Ring diameter was measured after 48 h incubation at room temperature. Results were compared with those of known standards.
Preparation of recombinant M. tuberculosis 65,000 protein. Lambda gtl 1 clone SKI 16 (in E. coli Y1089), encoding M. tuberculosis 65,000 protein, was a gift of T. Shinnick (Centers for Disease Control, Atlanta, GA). E. coli lysogens were grown in LB medium at 30°C until the OD6w was 1.0 and then warmed to 42°C for 20 min.
After additional culture at 37°C the cells were sedimented, resuspended in 100 mM sodium borate, pH 8.3, and 500 mM NaCl, and lysed by repeated freezing and thawing, addition of lysozyme, and brief sonication.
Western blot. H37Rv filtrate or sonicate, or E. coli lysate was mixed with an equal volume of reducing sample buffer (25% 0.5 M Tris-HCI, pH 6.8,4% SDS, 20% glycerol, 10% 2-mercaptoethanol) and heated at 100°C for 2 min. 50 ug protein was loaded in each lane of a 10% SDS-polyacrylamide gel (Bio-Rad Laboratories). After electrophoresis proteins were transferred to 0.2-Mm nitrocellulose paper (Bio-Rad Laboratories). Protein staining of transfers was performed using Aurodye (Janssen Life Sciences Products, Piscataway, NJ). Nonspecific binding was blocked by incubation with RPMI/FCS 20% for 2 h at 370C. MAbs were diluted fivefold in RPMI/FCS 10% and allowed to react overnight at 4°C. After extensive washing blots were incubated for 6 h with alkaline-phosphatase-conjugated anti-human 1g, anti-human IgG, or anti-human IgM (Sigma Chemical Co.) diluted 1:1,000 in 1% BSA/PBS. Alkaline phosphatase activity was detected using nitroblue tetrazolium and 5-bromo-4-chloro-3-indoyl phosphate in 100 mM Tris, pH 9.5, 100 mM NaCl, and 5 mM MgCI2.
Results
Establishment ofEB V-transformed B cell clones. Pleural fluid mononuclear cells were initially placed in three 2-ml wells of a 24-well tissue culture plate (Costar, Cambridge, MA) at a density of 2 X 106/well. Supernatant was tested weekly by ELISA for the presence of antibody to M. tuberculosis culture filtrate. As shown in Table I (14) , pleural mononuclear cell responses are preserved. This cell population contains increased numbers ofM. tuberculosis-reactive CD4+ T lymphocytes as compared with blood (15) (16) (17) (18) , and increased numbers of the helper-inducer (CD4+ CD45+) T cell subset (19) . Pleural fluid cells do not contain the adherent suppressor cells found among circulating cells that may be responsible for systemic immune unresponsiveness (20) . These findings suggest that local protective mechanisms are effective in containing the pleural infection despite the inadequacy of the systemic responses, and (23) . Their 65,000 protein has significant homology to a structural cell wall component of M. keprae and to heat shock proteins ofmany other bacteria (24) (25) (26) (27) . While the 65,000 protein appears to dominate both humoral and cellular immune responses in animals immunized with heat-killed mycobacteria (28), this does not appear to be true for human subjects, particularly with regard to cellular responses. Although antibodies or T cells recognizing M. tuberculosis 65,000 antigen can be detected in the blood of patients with leprosy or tuberculosis (29-31), none of 13 M. leprae-reactive human T cell clones, and only 2 of 22 M. tuberculosis-reactive human T cell clones identified recombinant 65,000 antigen of their respective spe- (42) . None of the IgG antibodies could be used satisfactorily for Western blotting.
Reactivity with mycobacterial arabinogalactan and arabinomannan has been described in -15% ofM. tuberculosisreactive murine MAbs, particularly those with broad patterns of reactivity (39) . As these polysaccharides are incapable of eliciting a delayed type hypersensitivity response or stimulating T cell blastogenesis in man (43), they are not likely to be useful either in the immunodiagnosis or prophylaxis of tuberculosis. None of the human MAbs were reactive with arabinogalactan or arabinomannan. This is the first published report of human M. tuberculosis-reactive MAbs. There is considerable interest in identification of potentially protective antigens of M. tuberculosis given the increasing incidence of tuberculosis worldwide, and the lack of evidence of protection afforded by immunization with BCG. To date, the M. tuberculosis DNA library developed by Young et al. has been screened only with murine MAbs. The present human MAbs may prove of value in the identification of recombinant mycobacterial antigens specifically recognized by the human immune response during the course of natural infection. The antigens obtained in this manner are of potential value for diagnosis of tuberculous infection and as vaccines.
